International Journal of Rheumatology / 2015 / Article / Tab 1 / Review Article
Gastric Antral Vascular Ectasia in Systemic Sclerosis: Current Concepts Table 1 Prevalence of GAVE in patients with systemic sclerosis.
Reference Cohort characteristics Prevalence of GAVE Other variables measured Ghrénassia et al. [18 ] Patients from European League Against Rheumatism Scleroderma Trials and Research. 49 patients were included (24 with diffuse cutaneous SSc). 1% Diminished DLCO value. Presence of anti-RNA-polymerase III antibodies. Higher association with anemia. Hung et al. [15 ] Patients from Scleroderma: Cyclophosphamide Or Transplant (SCOT) trial. 103 patients diagnosed by endoscopy. 22.3% No association between anti-RNA polymerase III and GAVE. Presence of vascular ectasia in other parts of the stomach. Ingraham et al. [19 ] Patients from the Division of Rheumatology at Georgetown University and Thomas Jefferson University. 28 patients, 17 with diffuse cutaneous and 11 with limited cutaneous systemic sclerosis. 4% of patients had anti-topoisomerase I antibody. Marie et al. [14 ] 264 patients with systemic sclerosis between 1900 and 2008. 5.7% Systemic sclerosis onset preceded watermelon stomach manifestations in 13 patients (86.7%).
Patients with diffuse cutaneous systemic sclerosis within 18 months of the first symptoms.